Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Internal Medicine Journal|March 19, 2021
Altered bowel habit and rectal bleeding in pregnancy: the importance of recognising undiagnosed inflammatory bowel diseaseGurpreet Singh, Ralley Prentice, David Langsford, et al.
Journal of Clinical Medicine|September 28, 2023
Are We Ready to Reclassify Crohn's Disease Using Molecular Classification?Shahed Kamal, Nikita Parkash, William Beattie, et al.
Endocrine Connections|October 28, 2020
No effect of 10 weeks erythropoietin treatment on lipid oxidation in healthy menJeyanthini Risikesan, Birgitte Nellemann, Britt Christensen, et al.
European Journal of Gastroenterology & Hepatology|September 18, 2024
Systematic review with meta-analysis of the effectiveness of subcutaneous biologics versus intravenous biologics in inflammatory bowel diseasesAlexander T Elford, Rishni Heldt, Shahed Kamal, et al.
Journal of Strength and Conditioning Research|December 24, 2015
Comparative Effects of Aerobic Training and Erythropoietin on Oxygen Uptake in Untrained HumansPeter Sieljacks, Line Thams, Birgitte Nellemann, et al.
Journal of Clinical Medicine|October 14, 2023
Benefits and Challenges of Treat-to-Target in Inflammatory Bowel DiseaseJack West, Katrina Tan, Jalpa Devi, et al.
Diagnostics (Basel, Switzerland)|September 28, 2024
Long-Term Follow Up of Patients Treated for Inflammatory Bowel Disease and Cytomegalovirus ColitisGurtej Singh, Clarissa Rentsch, William Beattie, et al.
Lipids in Health and Disease|September 19, 2016
Erythropoietin does not activate erythropoietin receptor signaling or lipolytic pathways in human subcutaneous white adipose tissue in vivoBritt Christensen, Birgitte Nellemann, Jens Otto L Jørgensen, et al.
Journal of Clinical Medicine|January 8, 2025
Future of Acute Severe Ulcerative Colitis-A Narrative ReviewLeshni Pillay, Janakan Selvarajah, Bridgette Andrew, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2022
Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, screening, diagnosis and managementSasha R Fehily, Aysha H Al-Ani, Jonathan Abdelmalak, et al.
Pageof 13